A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Translational precision medicine: an industry perspective
2021
Journal of Translational Medicine
AbstractIn the era of precision medicine, digital technologies and artificial intelligence, drug discovery and development face unprecedented opportunities for product and business model innovation, fundamentally changing the traditional approach of how drugs are discovered, developed and marketed. Critical to this transformation is the adoption of new technologies in the drug development process, catalyzing the transition from serendipity-driven to data-driven medicine. This paradigm shift
doi:10.1186/s12967-021-02910-6
pmid:34090480
fatcat:76rpj3jyybhvvavsas6rx5z6oa